# SAM #36E79726R0034

VA annual procurement of Ramipril capsules in seven strength and package configurations

**Buyer:** VA National Acquisition Center Pharmaceuticals
**Posted:** October 29, 2026
**Respond By:** November 23, 2026
**Identifier:** 36E79726R0034
**NAICS:** 424210, 325412

The Department of Veterans Affairs is seeking an annual supply of Ramipril capsules for participating federal health services.
- **Buyer and users:** Department of Veterans Affairs, through the VA National Acquisition Center; intended users are the VA, Department of Defense, Bureau of Prisons, and Indian Health Service.
- **Requested product:** Ramipril capsules in seven strength and bottle-size configurations, totaling an estimated 36,168 bottles annually.
  - 1.25 mg, 100 capsules per bottle: 2,930 bottles
  - 2.5 mg, 100 capsules per bottle: 2,498 bottles
  - 2.5 mg, 500 capsules per bottle: 1,611 bottles
  - 5 mg, 100 capsules per bottle: 6,018 bottles
  - 5 mg, 500 capsules per bottle: 2,704 bottles
  - 10 mg, 100 capsules per bottle: 15,956 bottles
  - 10 mg, 500 capsules per bottle: 4,451 bottles
- **OEMs and vendors:** No specific OEM or vendor is named in the opportunity.
- **Notable requirements:** The supplier must maintain an uninterrupted source of supply. Each product must be identified by the exact name on its label and have a unique National Drug Code (NDC); glass bottles are not acceptable.
- **Distribution and term:** Products will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. The contract has a one-year base period and four one-year options.

### Description

Page 2 of 2
Page 2 of 2
PRE-SOLICITATION NOTICE:  The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0034 for an unrestricted procurement for Ramipril capsules for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS).  The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items.  The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.  Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number.  Glass bottles are not acceptable.   Solicitation #Â 36E79726R0034 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 11/16/2026 with a tentative closing dateÂ of 11/30/2026.  The NAICS code for this procurement isÂ 325412.  Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov.  No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted.   Interested offerors are advised to continuously check this URL for any changes to this solicitation.  All responsible sources may submit an offer that if timely received, will be considered.  The point of contact for this procurement isÂ Amber Zavala.  Questions can be e-mailed to:Â amber.zavala@va.gov. 

The estimated annual requirements are as follows:
Description                     Size             Estimated Annual Requirements    
                                                                             
RAMIPRIL 1.25MG CAP  100/BT  2,930
RAMIPRIL 2.5MG CAP  100/BT  2,498
RAMIPRIL 2.5MG CAP   500/BT  1,611
RAMIPRIL 5MG CAP                       100/BT  6,018
RAMIPRIL 5MG CAP                       500/BT  2,704
RAMIPRIL 10MG CAP                      100/BT  15,956
RAMIPRIL 10MG CAP   500/BT  4,451

[View original listing](https://sam.gov/opp/dfb4dcac249c49929a568cd556ed5f9d/view)
